|
Quotes & Info
|
| IART > SEC Filings for IART > Form 8-K on 24-Oct-2012 | All Recent SEC Filings |
24-Oct-2012
Results of Operations and Financial Condition, Regulation FD D
The information contained in Item 2.02 of this Current Report on Form 8-K
(including the Press Release and selected historical financial information) is
being furnished and shall not be deemed "filed" for the purposes of Section 18
of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or
otherwise subject to the liabilities of that Section. The information contained
in Item 2.02 of this Current Report on Form 8-K (including the Press Release and
selected historical financial information) shall not be incorporated by
reference into any registration statement or other document pursuant to the
Securities Act of 1933, as amended, or the Exchange Act, except as shall be
expressly set forth by specific reference in any such filing.
Discussion of Adjusted Financial Measures
In addition to our GAAP results, we provide adjusted revenues, adjusted EBITDA,
adjusted EBITDA excluding stock-based compensation, adjusted net income and
adjusted earnings per diluted share. Adjusted revenues consist of growth in
total revenues excluding the effects of currency exchange rates on the current
period's revenues. The various measures of adjusted EBITDA consist of GAAP net
income, excluding: (i) depreciation and amortization, (ii) other income
(expense), net, (iii) interest income and expense, (iv) income taxes, (v) those
operating expenses also excluded from adjusted net income and, as appropriate
(vi) stock-based compensation expense. The measure of adjusted net income
consists of GAAP net income, excluding: (i) Plainsboro, New Jersey manufacturing
facility remediation costs; (ii) global enterprise resource planning ("ERP")
implementation charges; (iii) facility optimization charges; (iv) certain
employee termination charges; (v) discontinued product lines charges; (vi)
acquisition-related charges; (vii) impairment charges; (viii) European entity
restructuring charges; (ix) certain executive compensation charges; (x)
financing charges; (xi) convertible debt non-cash interest; (xii) intangible
asset amortization expense; and (xiii) income tax impact from adjustments and
other items. The adjusted earnings per diluted share measure is calculated by
dividing adjusted net income attributable to diluted shares by diluted weighted
average shares outstanding. Reconciliations of GAAP revenues to adjusted
revenues for the quarter ended September 30, 2012 and GAAP net income to
adjusted EBITDA, adjusted EBITDA excluding stock-based compensation and adjusted
net income, and GAAP earnings per diluted share to adjusted earnings per diluted
share for the quarters ended September 30, 2012 and 2011 appear in the financial
tables in the Press Release.
The Company believes that the presentation of adjusted revenues and the various
adjusted EBITDA, adjusted net income and adjusted earnings per diluted share
measures provides important supplemental information to management and investors
regarding financial and business trends relating to the Company's financial
condition and results of operations. Management uses non-GAAP financial measures
in the form of adjusted revenues, adjusted EBITDA, adjusted EBITDA excluding
stock-based compensation, adjusted net income and adjusted earnings per diluted
share when evaluating operating performance because we believe that the
inclusion or exclusion of the items described below, for which the amounts
and/or timing may vary significantly depending upon the Company's acquisition,
integration, and restructuring activities, for which the amounts are non-cash in
nature, or for which the amounts are not expected to recur at the same magnitude
as we implement certain tax planning strategies, provides a supplemental measure
of our operating results that facilitates comparability of our operating
performance from period to period, against our business model objectives, and
against other companies in our industry. We have chosen to provide this
information to investors so they can analyze our operating results in the same
way that management does and use this information in their assessment of our
core business and the valuation of our Company.
Adjusted revenues, adjusted EBITDA, adjusted EBITDA excluding stock-based
compensation, adjusted net income and adjusted earnings per diluted share are
significant measures used by management for purposes of:
supplementing the financial results and forecasts reported to the Company's board of directors;
evaluating, managing and benchmarking the operating performance of the Company;
establishing internal operating budgets;
determining compensation under bonus or other incentive programs;
enhancing comparability from period to period;
comparing performance with internal forecasts and targeted business models; and
evaluating and valuing potential acquisition candidates.
The measure of adjusted revenues that we report reflects the growth in total
revenues for the quarter ended September 30, 2012 adjusted for the effects of
currency exchange rates on current period revenues. We provide this measure
because changes in foreign currency exchange rates can distort our revenue
growth favorably or unfavorably, depending upon the strength of the U.S. dollar
in relation to the various foreign currencies in which we generate revenues. We
generate significant revenues outside the United States in multiple foreign
currencies including euros, British pounds, Swiss francs and Australian and
Canadian dollars. We believe this measure provides useful information to
determine the success of our international selling organizations in increasing
sales of products in their local currencies without regard to fluctuations in
currency exchanges rates, for which we have no control over.
The measure of adjusted net income reflects GAAP net income adjusted for one or
more of the following items, as applicable:
Plainsboro, New Jersey manufacturing facility remediation costs. These costs
represent expenses associated with remediation and related unplanned idle time
and underutilization at the Plainsboro, NJ manufacturing facility. Management
excludes this item when evaluating the Company's operating performance because
of the infrequent nature and the magnitude of this item.
Global ERP implementation charges. Systems implementation charges consist of the
non-capitalizable portion of internal labor and outside consulting costs related
to the implementation of a global ERP system. We have inherited many diverse
business processes and different information systems through our numerous
acquisitions. Accordingly, we are undertaking this initiative in order to
standardize business processes globally and to better integrate all of our
existing and acquired operations using one information system. Although
recurring in nature given the expected timeframe to complete the implementation
for our existing operations and our expectation to continue to acquire new
businesses and operations, management excludes these charges when evaluating the
operating performance of the Company because the frequency and amount of such
charges vary significantly based on the timing and magnitude of the Company's
implementation activities. In addition, with the global ERP project entering the
application development phase, more costs of the project will be capitalized
and, therefore, are not comparable to earlier periods.
Facility optimization charges. These charges, which include employee termination
and other costs associated with exit or disposal activities, costs related to
acquisition integration, costs related to transferring manufacturing and/or
distribution activities to different locations, result from rationalizing and
enhancing our existing manufacturing, distribution and administrative
infrastructure. Some of these cost-saving and efficiency-driven activities are
identified as opportunities in connection with acquisitions that provide the
Company with additional capacity or economies of scale. Although recurring in
nature given management's ongoing review of the efficiency of our manufacturing,
distribution and administrative facilities and operations, management excludes
these items when evaluating the operating performance of the Company because the
frequency and amount of such charges vary significantly based on the timing and
magnitude of the Company's rationalization activities and are, in some cases,
dependent upon opportunities identified in acquisitions, which also vary in
frequency and magnitude.
Certain employee termination charges. Certain employee termination and related
charges consist of charges related to senior management level terminations and
certain significant reductions in force that are not initiated in connection
with facility consolidations or manufacturing or distribution transfers.
Management excludes these items when evaluating the Company's operating
performance because these amounts do not affect our core operations and because
of the infrequent and/or large scale nature of these activities.
Discontinued product lines charges. These charges represent charges taken in
connection with product lines that the Company discontinues. Management excludes
this item when evaluating the Company's operating performance because
discontinued products do not provide useful information regarding the Company's
prospects for future performance.
Acquisition-related charges. Acquisition-related charges include up-front fees
and milestone payments that are expensed as incurred in connection with
acquiring licenses or rights to technology for which no product has been
approved for sale by regulatory
authorities and such approval is not reasonably assured at the time such
up-front fees or milestone payments are made, and in-process research and
development charges when accounting rules require them to be expensed, inventory
fair value purchase accounting adjustments, and legal, accounting and other
outside consultants expenses directly related to acquisitions. Inventory fair
value purchase accounting adjustments consist of the increase to cost of goods
sold that occur as a result of expensing the "step up" in the fair value of
inventory that we purchased in connection with acquisitions as that inventory is
sold during the financial period. Although recurring given the ongoing character
of our development and acquisition programs, these acquisition and in-licensing
related charges are not factored into the evaluation of our performance by
management after completion of development programs or acquisitions because they
are of a temporary nature, they are not related to our core operating
performance and the frequency and amount of such charges vary significantly
based on the timing and magnitude of our development and acquisition
transactions as well as the level of inventory on hand at the time of
acquisition.
Impairment charges. This represents impairment charges recorded against various
intangible assets, including completed or core technology, customer
relationships, and tradenames. Such impairments result primarily from management
decisions to discontinue or significantly reduce promoting certain product lines
or tradenames, the inability to incorporate existing product technologies into
product development programs, and other circumstances. Management excludes this
item when evaluating the Company's operating performance because of the
infrequent and non-cash nature of this activity.
European entity restructuring charges. These amounts represent charges recorded
in operating or non-operating expenses such as levies and fees paid to
government authorities, legal, tax, accounting and consulting fees, and foreign
currency gains and losses related to intercompany loan agreements incurred
directly as a result of reorganizing our European entities and transfers of
business assets between these legal entities. Management excludes this item when
evaluating the Company's operating performance because they are not related to
our core operating performance and the frequency and amount of such charges vary
significantly based on the timing and magnitude of our legal entity
restructuring activities.
Certain executive compensation charges. This charge related to extending our
former Chief Executive Officer's employment agreement. The charge was recognized
in the second quarter of 2011 upon the grant of contract stock units that were
fully vested at the time of the grant on May 17, 2011. Management excludes this
item when evaluating the Company's operating performance because of the
infrequent nature of this item.
Financing charges. These amounts represent expenses incurred in connection with
the refinancing of our senior credit facility in the second quarter of 2011.
These expenses related to (i) the remaining unamortized balance of previously
capitalized issuance costs relating to certain lenders who are no longer parties
to our revised senior credit facility and (ii) a portion of the new issuance
. . .
(d) Exhibits
1. Press release with attachments, dated October 24, 2012, issued by Integra LifeSciences Holdings Corporation
|
|